ATE508364T1 - Diagnoseverfahren für präeklampsie - Google Patents

Diagnoseverfahren für präeklampsie

Info

Publication number
ATE508364T1
ATE508364T1 AT06837479T AT06837479T ATE508364T1 AT E508364 T1 ATE508364 T1 AT E508364T1 AT 06837479 T AT06837479 T AT 06837479T AT 06837479 T AT06837479 T AT 06837479T AT E508364 T1 ATE508364 T1 AT E508364T1
Authority
AT
Austria
Prior art keywords
sbp
preeclampsia
proteinaceous
sflt
plgf
Prior art date
Application number
AT06837479T
Other languages
English (en)
Inventor
David Sogin
Donald Laird
Zhiguang Yu
Robert Doss
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37820640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE508364(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE508364T1 publication Critical patent/ATE508364T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Vehicle Body Suspensions (AREA)
  • Pressure Welding/Diffusion-Bonding (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
AT06837479T 2005-11-14 2006-11-14 Diagnoseverfahren für präeklampsie ATE508364T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73665905P 2005-11-14 2005-11-14
US11/367,126 US20070111326A1 (en) 2005-11-14 2006-03-03 Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
PCT/US2006/044059 WO2007059065A2 (en) 2005-11-14 2006-11-14 Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia

Publications (1)

Publication Number Publication Date
ATE508364T1 true ATE508364T1 (de) 2011-05-15

Family

ID=37820640

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06837479T ATE508364T1 (de) 2005-11-14 2006-11-14 Diagnoseverfahren für präeklampsie

Country Status (8)

Country Link
US (1) US20070111326A1 (de)
EP (1) EP1952156B1 (de)
JP (1) JP5225097B2 (de)
AT (1) ATE508364T1 (de)
CA (1) CA2629451A1 (de)
DE (1) DE602006021777D1 (de)
ES (1) ES2363609T3 (de)
WO (1) WO2007059065A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005022047A1 (de) 2005-05-09 2006-11-30 Dade Behring Marburg Gmbh Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung
US20080071151A1 (en) * 2006-06-30 2008-03-20 Sogin David C Method and Apparatus for Diagnosing Pre-eclampsia
EP1903339B1 (de) * 2006-09-20 2010-08-04 Roche Diagnostics GmbH Natriurethische Peptide und Plazenta-Wachstumfaktor/löslicher VEGF-Rezeptor unterscheiden zwischen mit der Plazenta verbundener Herzdysfunktion und mit Herzerkrankung verbundener Herzdysfunktion
DE102007038730A1 (de) * 2007-08-16 2009-02-19 Carl Zeiss Meditec Ag Nachweis des menschlichen Vascular Endothelial Growth Factor
CN101918834B (zh) * 2008-01-07 2014-05-28 奥索临床诊断有限公司 用于同时分析能够彼此络合的蛋白质的校准物/对照物
RU2010133157A (ru) 2008-01-07 2012-02-20 Орто-Клиникал Дайэгностикс, Инк. (Us) Определение комплекса sflt-1:ангиогенный фактор
US20100004306A1 (en) * 2008-06-18 2010-01-07 Abbott Laboratories PIGF-1 Assay and kits and components thereof
US8741287B2 (en) 2008-06-18 2014-06-03 Abbott Laboratories PlGF-1 assay and kits and components thereof
EP2368119B1 (de) * 2008-11-20 2014-04-23 PerkinElmer Health Sciences, Inc. Verfahren zur bestimmung des präeklampsierisikos unter verwendung von pigf-2- und pigf-3-markern
WO2010151329A1 (en) * 2009-06-24 2010-12-29 Seventh Sense Biosystems, Inc. Assays involving colorimetric signaling
EP2776839B1 (de) * 2011-11-09 2017-08-30 Roche Diagnostics GmbH Dynamik des sflt-1 oder endoglin/plgf-verthältnisses als indikator für drohende präeklampsie und/oder drohendes hellp-syndrom
SG11201407667UA (en) 2012-06-27 2015-02-27 Hoffmann La Roche MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD
RU2724013C2 (ru) 2015-06-19 2020-06-18 Сера Прогностикс, Инк. Пары биологических маркеров для предсказания преждевременных родов
BR112018015532A2 (pt) * 2016-02-29 2018-12-26 Hoffmann La Roche métodos para o diagnóstico de pré-eclâmpsia, para avaliar a gravidade da pré-eclâmpsia, e para o monitoramento pré-eclâmpsia, usos de biomarcador, kit adaptado para a realização do método e dispositivo adaptado para diagnosticar se uma paciente sofre de pré-eclâmpsia
WO2019036032A1 (en) 2017-08-18 2019-02-21 Sera Prognostics, Inc PREGNANCY CLOCK PROTEINS FOR PREDICTING THE DATE AND MOMENT OF BIRTH
KR20200109293A (ko) 2017-09-13 2020-09-22 프로제너티, 인크. 자간전증 바이오마커 및 관련된 시스템 및 방법
WO2021113710A1 (en) 2019-12-04 2021-06-10 Progenity, Inc. Assessment of preeclampsia using assays for free and dissociated placental growth factor

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0114528A3 (de) * 1982-12-27 1986-05-14 Trustees Of Boston University Abscheidung von Zellen auf Platten unter Verwendung von Nicht-Antikörperliganden
WO1988001058A1 (en) * 1986-08-06 1988-02-11 Roger Philip Ekins Determination of analyte concentration using two labelling markers
EP0960334A1 (de) * 1996-12-20 1999-12-01 Ludwig Institute For Cancer Research Vegf-b/rezeptorkomplex und anwendung
CA2348753A1 (en) * 1998-10-30 2000-05-11 Merska B.V. Screening for analytes using labeled receptors
CA2394015C (en) * 1999-12-20 2013-11-05 Immunex Corporation Tweak receptor
WO2002099421A2 (en) * 2001-05-18 2002-12-12 Thomas Jefferson University Specific microarrays for breast cancer screening
WO2003022874A1 (fr) * 2001-09-12 2003-03-20 Beijing Institute For Cancer Research Peptides antagonistes du recepteur flt-1 du vegr
EP1451579A4 (de) * 2001-11-19 2005-12-28 Protometrix Inc Verfahren zur verwendung eines nicht-antikörper-proteins zum nachweis und zur messung eines analyten
JP5650876B2 (ja) * 2002-07-19 2015-01-07 ベス・イスラエル・ディーコニス・メディカル・センター 子癇前症または子癇の診断方法および治療方法
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
CA2539430C (en) * 2003-09-23 2015-03-17 The General Hospital Corporation Screening for gestational disorders with sex hormone binding globulin as biomarker
EP1530047A1 (de) * 2003-11-07 2005-05-11 Roche Diagnostics GmbH Proximale Markermoleküle der Arterienthrombose und der Entzündung zur Risikostratifizierung einer koronaren Herzkrankheit
EP1615035B1 (de) * 2004-07-07 2007-06-06 F.Hoffmann-La Roche Ag Kombinationen von Markern zum Nachweis von typ 1 und 2 Diabetes
EP1839056B1 (de) * 2004-12-21 2011-08-03 Yale University Präeklampsie-diagnose

Also Published As

Publication number Publication date
US20070111326A1 (en) 2007-05-17
DE602006021777D1 (de) 2011-06-16
ES2363609T3 (es) 2011-08-10
EP1952156A2 (de) 2008-08-06
WO2007059065A2 (en) 2007-05-24
JP5225097B2 (ja) 2013-07-03
JP2009516170A (ja) 2009-04-16
WO2007059065B1 (en) 2007-09-13
CA2629451A1 (en) 2007-05-24
EP1952156B1 (de) 2011-05-04
WO2007059065A3 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
DE602006021777D1 (de) Diagnoseverfahren für präeklampsie
WO2006126008A3 (en) Improved immunoassay methods
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
NZ600828A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
TW200617380A (en) Concentration determination in a diffusion barrier layer
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
IL157380A0 (en) Mediator stabilized reagent compositions and methods for their use in electrochemical analyte detection assays
MX2009006205A (es) Inmunoensayo de multiples analitos.
BRPI0812875A2 (pt) " método pra identificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, anticorpo específico para proteína ligante de heparina, método pra reduzir o risco de um indivíduo desenvolver sépsis severa, e, kit de teste ".
ATE474228T1 (de) Reagenz für hämoglobinabbau
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
ATE395812T1 (de) Methoden zur vorhersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests
TW200613729A (en) Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento
EP1476757A4 (de) Verfahren und kit zur krebsvorhersage
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
ATE549417T1 (de) Diagnoseverfahren für osteoarthritis
McKiernan et al. NextGen serology: leveraging mass spectrometry for protein-based human body fluid identification
SI1977244T1 (sl) Razlikovanje med bakterijskim meningitisom in virusnim meningitisom
WO2008035204A3 (en) Prediction and prophylactic treatment of type 1 diabetes
BRPI0618435A2 (pt) composição reagente de sensor teste tendo polìmeros de celulose adaptada para auxiliar na determinação de uma concentração de analito de uma amostra fluida, bem como processo de determinação de uma concentração de analito de uma amostra fluida
Slocombe et al. A method for determining the concentration of haptoglobin in cattle blood following haemolysis caused at collection
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
CA2586654A1 (en) Use of asc as a marker for colorectal cancer
WO2022229421A3 (en) Strem1 marker panels for early detection of sepsis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties